Life at the front: Dissecting bacterial-host interactions at the ocular surface

Ocular Surface

Volumn 5, Issue 3, 2007, Pages 213-227

  Evans, David J ^a,d   McNamara, Nancy A ^c   Fleiszig, Suzanne M J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

Bacteria; Contact lenses; Cornea; Epithelium; Innate defense; Keratitis; P. aeruginosa; Pathogenesis; Pseudomonas; Tears; Type III secretion system

Indexed keywords

ANTIBIOTIC AGENT; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; EXOENZYME S; IMMUNOGLOBULIN A; LACTOFERRIN; LIPOCALIN; LYSOZYME; MEMBRANE PROTEIN; MUCIN; PHOSPHOLIPASE A2; POLYPEPTIDE ANTIBIOTIC AGENT; SURFACTANT PROTEIN D; TEAR PROTEIN; UVOMORULIN; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BLINKING; CELL INVASION; CELL SURFACE; CORNEA EPITHELIUM; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EYELID CLOSURE; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; KERATITIS; LACRIMAL FLUID; NONHUMAN; PSEUDOMONAS AERUGINOSA; BACTERIAL EYE INFECTION; CORNEA; CORNEA ULCER; MICROBIOLOGY; PATHOLOGY; REVIEW; VIRULENCE;

ANTI-BACTERIAL AGENTS; CORNEA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRULENCE;

EID: 38449122374     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70612-2     Document Type: Article

References (204)

1. Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 1999;354:181-5
2. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis: predisposing factors and morbidity. Ophthalmology 2006;113:109-16
3. Morgan PB, Efron N, Hill EA, et al. Incidence of keratitis of varying severity among contact lens wearers. Br J Ophthalmol 2005;89:430-6
4. Laspina F, Samudio M, Cibils D, et al. Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol 2004;242:204-9
5. Mah-Sadorra JH, Najjar DM, Rapuano CJ, et al. Serratia corneal ulcers: a retrospective clinical study. Cornea 2005;24:793-800
6. Wang AG, Wu CC, Liu JH. Bacterial corneal ulcer: a multivariate study. Ophthalmologica 1998;212:126-32
7. Ledbovitch I, Lai TF, Senarath L, et al. Infectious keratitis in South Australia: emerging resistance to cephazolin. Eur J Ophthalmol 2005;15:23-6
8. Zhu H, Conibear TC, Bandara R, et al. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res 2006;31:297-306
9. Falkow S. Microbes as tools for cell biology. Introduction. Methods Cell Biol 1994;45:xv-xvi
10. McIntosh RS, Cade JE, Al-Abed M, et al. The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci 2005;46:1379-85
11. McDermott AM, Redfern RL, Zhang B, et al. Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2003;44:1859-65
12. McNamara NA, Van R, Tuchin OS, et al. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res 1999;69:483-90
13. Ni M, Evans DJ, Hawgood S, et al. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun 2005;73:2147-56
14. Xue ML, Thakur A, Willcox MD, et al. Role and regulation of CXC-chemokines in acute experimental keratitis. Exp Eye Res 2003;76:221-31
15. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res 2004;23:1-30
16. Szliter EA, Barrett RP, Gabriel MM, et al. Pseudomonas aeruginosa-induced inflammation in the rat extended-wear contact lens model. Eye Contact Lens 2006;32:12-8
17. Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res 2004;78:379-88
18. Akira S, Hoshino K. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling. J Infect Dis 2003; 187 Suppl 2:S356-63
19. Brito BE, Zamora DO, Bonnah RA, et al. Toll-like receptor 4 and CD14 expression in human ciliary body and TLR-4 in human iris endothelial cells. Exp Eye Res 2004;79:203-8
20. Johnson AC, Heinzel FP, Diaconu E, et al. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci 2005;46:589-95
21. Chowdhury P, Sacks SH, Sheerin NS. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol 2006; 145:346-56
22. Zhang J, Xu K, Ambati B, et al. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aerugiosa flageilin. Invest Ophthalmol Vis Sci 2003;44:4247-54
23. Greene CM, Carroll TP, Smith SG, et al. TLR-induced inflammation in cystic fibrosis and noii-cystic fibrosis airway epithelial cells. J Immunol 2005;174:1638-46
24. Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science 2003;300:1524-5
25. Alvarez JI. Inhibition of Toll Like Receptor immune responses by microbial pathogens. Front Biosci 2005;10:582-7
26. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 2002;270:109-20
27. Froy O. Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways. Cell Microbiol 2005;7:1387-97
28. Juris SJ, Shao F, Dixon JE. Yersinia effectors target mammalian signalling pathways. Cell Microbiol 2002;4:201-11
29. Islam D, Bandholtz L, Nilsson J, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a poten tial regulator. Nat Med 2001;7:180-5
30. Espinosa A, Alfano JR. Disabling surveillance: bacterial type III secretion system effectors that suppress innate immunity. Cell Microbiol 2004;6:1027-40
31. Garau J, Gomez L. Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 2003;16:135-43
32. Challacombe SJ, Naglik JR, The effects of HIV infection on oral mucosal immunity. Adv Dent Res 2006;19:29-35
33. Fantry L. Gastrointestinal infections in the immunocompromised host. Curr Opin Gastroenterol 2002;18:34-9
34. Peraira JR, Segovia J, Arroyo R, et al. High incidence of severe infections in heart transplant recipients receiving tacrolimus. Transplant Proc 2003;35:1999-2000
35. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004;39 Suppl 1:S25-31
36. Lopez Dupla M, Martinez JA, Vidal F, et al. Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes. J Intern Med 2005;258:172-80
37. Hazlett LD. Role of innate and adaptive immunity in the pathogenesis of keratitis. Ocul Immunol Inflamm 2005;13:133-8
38. Ly CN, Pham JN, Badenoch PR, et al. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin. Clin Experiment Ophthalmol 2006;34:44-50
39. Pachigolla G, Blomquist P. Cavanagh HD. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens 2007;33:45-9
40. Fleiszig SM, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun 1995;63:4072-7
41. Fleiszig SM, Zaidi TS, Preston MJ, et al. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun 1996;64:2288-94
42. Cowell BA, Weissman BA, Yeung KK, et al. Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000. Cornea 2003;22:131-4
43. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 1997;65:579-86
44. Evans DJ, Kuo TC, Kwong M, et al. Mutation of csk, encoding the C-terminal Src kinase, reduces Pseudomonas aeruginosa internalization by mammalian cells and enhances bacterial cytotoxiicity. Microb Pathog 2002;33:135-43
45. Fleiszaig SM, Zaidi TS, Fletcher EL, et al. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun 1994;62:3485-93
46. Lee EJ, Cowell BA, Evans DJ, et al. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest Ophthalmol Vis Sci 2003;44:3892-8
47. Lee EJ, Evans DJ, Fleiszig SM. Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model. Invest Ophthalmol Vis Sci 2003;44:5220-7
48. Zolfaghar I, Evans DJ, Ronaghi R, et al. Type III secretion-dependent modulation of innate immunity as one-of multiple factors regulated by Pseudomonas aeruginosa RetS. Infect Immun 2006;74:3880-9
49. Finck-Barbancon V, Goranson J, Zhu L, et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 1997;25:547-57
50. Sato H, Frank DW, Hillard CJ, et al. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J 2003;22:2959-69
51. Pankhaniya RR, Tamura M, Allmond LR, et al. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU. Crit Care Med 2004;32:2293-9
52. Fleiszig SM, Lee EJ, Wu C, et al. Cytotoxic strains of Pseudomonas aeruginosa can damage the intact corneal surface in vitro. CLAO J 1998;24:41-7
53. Lomholt JA, Poulsen K, Kilian M. Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun 2001;69:6284-95
54. Feltman H, Schulert G, Khan S, et al, Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 2001;147:2659-69
55. Hauser AR, Cobb E, Bodi M, et al. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 200230:521-8
56. Frank Dw, Nair G, Schweizer HP. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus. Infect Immun 1994;62:554-63
57. Frank DW The exoc.izyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 1997;26:621-9
58. Yahr TL, Wolfgang MC. Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system. Mol Microbiol 2006;62:631-40
59. Hueck CJ. Type III protein secretion systerms in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998;62:379-433
60. Andriesse GI, Verhoef J. Nosocomial pneumonia: rationalizing the approach to empirical therapy. Treat Respir Med 2006;5:11-30
61. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-92
62. Barbieri JT, Sun J. Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol 2004;152:79-92
63. Yahr TL, Vallis AJ, Hancock MK, et al. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci U S A 1998;95:13899-904
64. Cowell BA, Evans DJ, Fleiszig SM. Actin cytoskeleton disruption by ExoY and its effects on Pseudomonas aeruginosa invasion. FEMS Microbiol Lett 2005;250:71-6
65. Garrity-Ryan L, Kazmierczak B, Kowal R, et al. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect Immun 2000;68:7100-13
66. Krall R, Sun J, Pederson KJ, et al. In vivo rho GTPase-activity protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun 2002;70:360-7
67. Rocha CL, Coburn J, Rucks EA, et al. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect Immun 2003;71:5296-305
68. Garrity-Ryan L, Shafikhani S, Balachandran P eL al. The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities. Infect Immun 2004;72:546-58
69. Yahr TL, Barbieri JT, Frank DW. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. J Bacteriol 1996;178:1412-9
70. Olson JC, McGuffie EM, Frank DW. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect Immun 1997;65:248-56
71. Olson JC, Fraylick JE, McGuffie EM, CL al. Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S. Infect Immun 1999;67:2847-54
72. Fraylick JE, La Rocque JR, Vincent TS, et al. Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function. Infect Immun 2001;69:5318-28
73. DiNovo AA, Schey KL, Vachon WS, et al. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S. Biochemistry 2006; 45:4664-73
74. Jia J, Wang Y. Zhou L, et al. Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells. Infect Immun 2006;74:6557-70
75. Dacheux D, Goure J, Chabert J, et al. Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol Microbiol 2001;40:76-85
76. Dacheux D, Toussaint B, Richard M, et al. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Infect Immun 2000;68:2916-24
77. Lee VT, Smith RS, Tummler B, et al. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun 2005;73:1695-705
78. Ader F, Le Berre R, Faure K, et al. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system. Infect Immun 2005;73:4263-71
79. Vance RE, Rietsch A, Mekalanos JJ. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 2005;73:1706-13
80. Shaver CM, Hauser AR. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 2004;72:6969-77
81. Lee A, Hazlett CB, Chow S, et al. HA to minimize inappropriate utilization of Accident and Emergency Departments: improve the validity of classifying the general practice cases amongst the A&E attendees. Health Policy 2003;66:159-68
82. Cowell BA, Chen DY, Frank DW, et al. ExoT of cytotoxic Pseudomonas aeruginosa. prevents uptake by corneal epithelial cells. Infect Immun 2000;68:403-6
83. Evans DJ, Frank DW, Finck-Barbancon V, et al. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity. Infect Immun 1998;66:1453-9
84. Cowell BA, Twining SS, Hobden JA, et al. Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology 2003;149:2291-9
85. Goodman AL, Kulasekara B, Rietsch A, et al. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell 2004;7:745-54
86. Smith RS, Wolfgang MC, Lory S. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia. Infect Immun 2004;72:1677-84
87. Fleiszig SM, Evans DJ, Do N, et al. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun 1997;65:2861-7
88. Pier GB, Grout M, Zaidi TS, et al. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 1996;271:64-7
89. Zaidi TS, Fleiszig SM, Preston MJ, et al. Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 1996;37:976-86
90. Fleiszig SM, Arora SK, Van R, et al. FlhA, a component of the flagellum assembly apparatus of Pseudomonas aeruginosa, plays a role in internalization by corneal epithelial cells. Infect Immun 2001;69:4931-7
91. Zolfaghar I, Evans DJ, Fleiszig SM. Twitching motility contributes to the role of pili in corneal infection caused by Pseudomonas aeruginosa. Infect Immun 2003;71:5389-93
92. Zaidi TS, Lyczak J, Preston M, et al. Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis. Infect Immun 1999;67:1481-92
93. Devidas S, Guggino WB. CFTR: domains, structure, and function. J Bioenerg Biomembr 1997;29:443-51
94. Pier GB. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci U S A 2000;97:8822-8
95. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci U S A 1997; 94:12088-93
96. Grassme H, Jendrossek V, Riehle A, et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 2003;9:322-30
97. Kowalski MP, Pier GB. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 2004;172:418-25
98. Yamamoto N, Yamamoto N, Petroll MW, et al. Internalization of Pseudomonas aeruginosa is mediated by lipid rafts in contact lens-wearing rabbit and cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci 2005;46:1348-55
99. Yamamoto N, Yamamoto N, Petroll MW, et al. Regulation of Pseudomonas aeruginosa internalization after contact lens wear in vivo and in serum-free culture by ocular surface cells. Invest Ophthalmol Vis Sci 2006;47:3430-40
100. Ladage PM, Yamamoto K, Ren DH, et al. Effects of rigid and soft contact lens daily wear on corneal epithelium, tear lactate dehydrogenase, and bacterial binding to exfoliated epithelial cells. Ophthalmology 2001;108:1279-88
101. Comolli JC, Waite LL, Mostov KE, et al. Pili binding to asialo-GMI on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa. Infect Immun 1999;67:3207-14
102. DiMango E, Zar HJ, Bryan R, et al. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995;96:2204-10
103. DiMango E, Ratner AJ, Bryan R, et al. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998;101:2598-605
104. McNamara N, Khong A, McKemy D, et al. ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor. Proc Natl Acad Sci U S A 2001;98:9086-91
105. Soong G, Reddy B, Sokol S, et al. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 2004;113:1482-9
106. Evans DJ, Maltseva IA, Wu J, et al. Pseudomonas aeruginosa internalization by corneal epithelial cells involves MEK and ERK signal transduction proteins. FEMS Microbiol Lett 2002;213:73-9
107. Esen M, Grassme H, Riethmuller J, et al. Invasion of human epithelial cells by Pseudomonas aeruginosa involves src-like tyrosine kinases p60Src and p59Fyn. Infect Immun 2001;69:281-7
108. Kierbel A, Gassama-Diagne A, Mostov K, et al. The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell 2005;16:2577-85
109. Fleiszig SM, Vallas V, Jun CH, et al. Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor. Infect Immun 1998;66:3443-6
110. Kazmierczak BI, Mostov K, Engel JN. Epithelial cell polarity alters Rho-GTPase responses to Pseudomonas aeruginosa. Mol Biol Cell 2004;15:411-9
111. Evans D, Kuo T, Kwong M, et al. Pseudomonas aeruginosa strains with lipopolysaccharide defects exhibit reduced intracellular viability after invasion of corneal epithelial cells. Exp Eye Res 2002;75:635-43
112. Engel LS, Hobden JA, Moreau JM, et al. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci 1997;38:1535-42
113. Gupta SK, Masinick SA, Hobden JA, et al, Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea. Exp Eye Res 1996;62:641-50
114. Twining SS, Kirschner SE, Malinke LA, et al. Effect of Pseudomonas aeruginosa clastase, alkaline protease, and exotoxin A on corneal protemases and proteins. Invest Ophthalmol Vis Sci 1993; 34:2699-712
115. Engel LS, Hill JM, Moreau JM, et al. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci 1998;39:662-5
116. Marquart ME, Caballero AR, Chormnawang M, et al. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Invest Ophthalmol Vis Sci 2005;46:3761-8
117. Kernacki KA, HobdenTA, Hazlett LD, et al. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci 1995;36:1371-8
118. Miyajima S, Akaike T, Matsumoto K, et al. Matrix metalloproteinases induction by pseudomonal vinilence factors and inflammatory cytokines in vitro. Microb Pathog 2001;31:271-81
119. Pillar CM, Hobden JA. Pseudomonas aeruginosa exotoxin A and keratitis in mice. Invest Ophthalmol Vis Sci 2002;43:1437-44
120. Dasgupta N, Wolfgang MC, Goodman AL, et al. A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 2003;50:809-24
121. Ventre I, Goodman AL, Vallet-Gely I, et al. Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regula Lory RNA and virulence genes. Proc Natl Acad Sci U S A 2006;103:171-6
122. Smith RS, Iglewski BH. P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 2003;6:56-60
123. Stover CK, Pharn XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000;406:959-64
124. Rodrigue A, Quentin Y, Lazdunski A, et al. Two-component systems in Pseudomonas aeruginosa: why so many? Trends Microbiol 2000;8:498-504
125. de Kievit TR, Kakai Y, Register JK, et al. Role of the Pseudomonas aeruginosa las and rh1 quorum-sensing systems in rh11 regulation. FEMS Microbiol Lett 2002;212:101-6
126. Kay E, Humair B, Denervaud V, et al. Two GacA-dependent small RNAs ruodulate the quorum-sensing response in Pseudomonas aeruginosa. J Bacteriol 2006;188:6026-33
127. Remmann C, Beyeler M, Latifi A, et al. The global activator GacA of Pseudomonas aeruginosa. PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase. Mol Microbiol 1997;24:309-19
128. Zolfaghar I, Angus AA, Kang PJ, et al. Mutation of rets, encoding a putative hybrid two-component regulatory protein in Pseudomonas aeruginosa, attenuates multiple virulence mechanisms. Microbes Infect 2005;7:1305-16
129. Laskowski MA, Kazmierczak BI. Mutational analysis of RetS, an unusual sensor kinase-response regulator hybrid required for Pseudomonas aeruginosa virulence. Infect Immun 2006;74:4462-73
130. Zhu H, Bandara R, Combear TC, et al. Pseudmonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. Invest Ophthalmol Vis Sci 2004;45:1897-903
131. Laskowski MA, Osborn E, Kazmierczak BI. A novel sensor kinase-response regulator hybrid regulates type III secretion and is required for virulence in Pseudomonas aeruginosa. Mol Microbiol 2004; 54:1090-103
132. Bleves S, Soscia C, Nogueira-Orlandi P, et al. Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J Bacteriol 2005;187:3898-902
133. Hueffer K, Galan JE. Salmonella-induced rnacrophage death: multiple mechanisms, different outcomes. Cell Microbiol 2004;6:1019-25
134. Fierer J, Guiney DG. Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J Clin Invest 2001;107:775-80
135. Sansonetti P. Phagocytosis of bacterial pathogens: implications in the host response. Semin Immunol 2001;13:381-90
136. Fleming A, Allison V. Observations on a bacteriolytic ferment found in secretions and tissues. Br J Experiment Pathol 1922;3:252-60
137. Qu XD, Lehrer RI. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun 1998;66:2791-7
138. Donaldson DM, Tew JG. beta-Lysin of platelet origin. Bacteriol Rev 1977;41:501-13
139. Haynes RJ, Tighe PJ, Dua HS. Innate defence of the eye by anti-microbial defensin peptides. Lancet 1998;352:451-2
140. Zhou L, Huang LQ, Beuerman RW, et al. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res 2004;3:410-6
141. Broekhuyse RM. Tear lactoferrin: a bactenostatic and complexing protein. Invest Ophthalmol 1974;13:550-4
142. Fluckinger M, Haas H, Merschak P, et al. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother 2004;48:3367-72
143. Williams RC, Gibbons RJ. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 1972;177:697-9
144. Masinick SA, Montgomery CP, Montgomery PC, et al. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Invest Ophthalmol Vis Sci 1997;38:910-8
145. Fleiszig SM, Zaidi TS, Ramphal R, et al. Modulation of Pseudomonas aeruginosa adberence to the corneal surface by mucus. Infect Immun 1994;62:1799-804
146. Fleiszig SM, Kwong MS, Evans DJ. Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid. Infect Immun 2003;71:3866-74
147. McNamara NA, Andika R, Kwong M, et al. Interaction of Pseudomonas aeruginosa with human Lear fluid components. Curr Eye Res 2005;30:517-25
148. Whitsett JA. Surfactant proteins in innate host defense of the lung. Biol Neonate 2005;88:175-80
149. Kishore U, Greenhough TJ, Waters P, et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 2006;43:1293-315
150. Hrdlickova-Cela E, Plzak J, Smetana K Jr, et al. Detection of galectin-3 in tear fluid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and conjunctival epithelium. Br J Ophthalmol 2001;85:1336-40
151. Rogers HJ, Synge C. Bacteriostatic effect of human milk on Escherichia coli: the role of IgA. Immunology 1978;34:19-28
152. Selinger DS, Selinger RC, Reed AT. Resistance to infection of the external eye: the role of tears. Surv Ophthalmol 1979;24:33-8
153. Sack RA, Beaton A, Sathe S, et al. Towards a closed eye model of the pre-ocular tear layer. Prog Retin Eye Res 2000;19:649-68
154. Tsai PS, Evans JE, Green KM, et al. Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol 2006;90:372-7
155. Zhou L, Beuerman RW, Foo Y, et al. Characterisation of human tear proteins using high-resolution mass spectrometry. Ann Acad Med Singapore 2006;35:400-7
156. Li N, Wang N, Zheng J, et al. Characterization of human tear proteome using multiple proteomic analysis techniques. J Proteome Res 2005;4:2052-61
157. Sack RA, Conradi L, Krumholz D, et al. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci 2005;46:1228-38
158. McNamara NA, Polse KA, Brand RJ, et al. Tear mixing under a soft contact lens: effects of lens diameter. Am J Ophthalmol 1999;127:659-65
159. Li L, Ren DH, Ladage PM, et al. Annexin V binding to rabbit corneal epithelial cells following overnight contact lens wear or eyelid closure. CLAO J 2002;28:48-54
160. Cavanagh HD, Ladage PM, Li SL, et al. Effects of daily and overnightwear of a novel hyper oxygen-transmissible soft contact lens on bacterial binding and corneal epithelium: a 13-month clinical trial. Ophthalmology 2002;109:1957-69
161. Mengaud J, Ohayon H, Gounon P et al. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell 1996;84:923-32
162. Hilkens J, Ligtenberg MJ, Vos HL, et al. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 1992;17:359-63
163. Devalia JL, Godfrey RW, Sapsford RJ, et al. No effect of histamine on human bronchial epithelial cell permeability and tight junctional integrity in vitro. Eur Respir J 1994;7:1958-65
164. Gipson IK, Spurr-Michaud S, Argueso P, et al. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 2003;44:2496-506
165. Robertson DM, Li L, Fisher S, et al. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci 2005;46:470-8
166. Yamaya M, Finkbeiner WE, Chun SY, et al. Differentiated structure and function of cultures from human tracheal epithelium. Am J Physiol 1992;262:L713-24
167. Argueso P, Tisdale A, Spurr-Michalad S, et al. Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye. Invest Ophthalmol Vis Sci 2006;47:113-9
168. Ramphal R, Houdret N, Koo L, et al. Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis. Infect Immun 1989;57:3066-71
169. McNamara NA, Fleiszig SM. Human tear film components bind Pseudomonas aeruginosa. Adv Exp Med Biol 1998;438:653-8
170. Panjwani N, Zhao Z, Raizman MB, et al. Pathogenesis of corneal infection: binding of Pseudomonas acruginosa to specific phosphotipids. Infect Immun 1996;64:1819-25
171. Haynes RJ, Tighe PJ, Dua HS. Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol 1999;83:737-41
172. Gordon YJ, Huang LC, Romanowski EG, et al. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res 2005;30:385-94
173. Goldman MJ, Anderson GM, Stolzenberg ED, et al. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553-60
174. Bals R, Wang X, Meegalla RL, et al. Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immun 1999;67:3542-7
175. McDermott AM, Redfern RL, Zhang B. Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr Eye Res 2001;22:64-7
176. Kumar A, Zhang J, Yu FS. Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells. Microbes Infect 2006;8:380-9
177. Huang LC, Petkova TD, Reins RY, et al. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci 2006;47:2369-80
178. Kernacki KA, Barrett RP, Hobden JA, et al. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection. J Immunol 2000;164:1037-45
179. Kernacki KA, Berk RS. Characterization of the inflammatory response induced by corneal infection with Pseudomonas aeruginosa. J Ocul Pharmacol 1994;10:281-8
180. Xue ML, Willcox MD, Lloyd A, et al. Regulatory role of IL-1 beta in the expression of IL-6 and IL-8 in human corneal epithelial cells during Pseudomonas aeniginosa colonization. Clin Experiment Ophthalmol 2001;29:171-4
181. Thakur A, Xue M, Stapleton F et al. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun 2002;70:2187-97
182. McClellan SA, Huang X, Barrett RP, et al. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice. J Immunol 2003;170:5219-27
183. Yamagami S, Yokoo S, Usui T, et al. Distinct populations of dendritic cells in the normal human donor corneal epithelium. Invest Ophthalmol Vis Sci 2005;46:4489-94
184. Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem Immunol Allergy 2007;92:58-70
185. Gura T. Innate immunity. Ancient system gets new respect. Science 2001;291:2068-71
186. Du JW, Zhang F, Capo-Aponte JE, et al. AsialoGM1-mediated IL-8 release by human corneal epithelial cells requires coexpression of TLR5. Invest Ophthalmol Vis Sci 2006;47:4810-8
187. Huang X, Barrett RP, McClellan SA, et al. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2005;46:4209-16
188. Huang X, Du W, McClellan SA, et al. TLR4 is required for host resistance
189. Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol 2006;90:103-8
190. Kumar A, Yu FS. Toll-like receptors and corneal innate immunity. Curr Mol Med 2006;6:327-37
191. Yu FS, Hazlett LD. Toll-like receptors and the eye. Invest Ophthalmol Vis Sci 2006;47:1255-63
192. Rosenbaum JT, Planck SR, Davey MP, et al. With a mere nod, uveitis enters a new era. Am J Ophthalmol 2003;136:729-32
193. Stapleton F, Willcox MD, Sansey N, et al. Ocular microbiota and polymorphonuclear leucocyte recruitment during overnight contact lens wear. Aust N Z J Ophthalmol 1997;25 Suppl 1:S33-5
194. Lawin-Brussel CA, Refojo MF, Leong FL, et al. Scanning electron microscopy of the early host inflammatory response in experimental Pseudomonas keratitis and contact lens wear. Cornea 1995;14:355-9
195. Rosen H. Bacterial responses to neutrophil phagocytosis. Curr Opin Hematol 2004;11:1-6
196. Fick RB Jr, Baltimore RS, Squier SU, et al. IgG proteolytic activity of Pseudomonas aerugiriosa in cystic fibrosis. J Infect Dis. 1985;151:589-98
197. Mariencheck WI, Alcorn JF, Palmer SM, et al. Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol 2003;28:528-37
198. Malloy JL, Veldhuizen RA, Thibodeaux BA, et al. Pseudomonas aerugirosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol 2005;288:L409-18
199. Alcorn JF, Wright JR. Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem 2004;279:30871-9
200. Matheson NR, Potempa J, Travis J. Interaction of a novel form of Pseudomonas aeruginosa alkaline protease (aeruginolysin) with interleukin-6 and interleukin-8. Biol Chem 2006:387:911-5
201. Gomez MI, Sokol SH, Muir AB, et al. Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. J Immunol 2005; 175:1930-6
202. Smitha S, Lalitha P, Prajna VN, et al. Susceptibility trends of pseudomonas species from corneal ulcers. Indian J Med Microbiol 2005:23:168-71
203. Lee EJ, Truong TN, Mendoza MN, et al. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics. Curr Eye Res 2003;27:289-99
204. Cowley SC, Myltseva SV, Nano FE. Phase variation in Francisella t ilarensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol Microbiol 1996;20:867-74